Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
350 participants
INTERVENTIONAL
2009-08-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
METHODS: The investigators will randomize 350 patients in two groups: group 1 receives a CardioPAT cell saver device (175 patients), group 2 doesn't receive any cell saver device. The incidence of allogenic blood transfusion and clinical outcome in both groups are evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The CardioPAT Project: A Randomized Trial
NCT02058134
Cell Savers and Blood Quality
NCT02046824
Drainage Technique in CABG
NCT07194798
Retransfusion or Not of Cardiotomy Blood
NCT04574128
Blood Conservation in Adult Cardiac Surgery, What is the Way Forward in Today's Practice?
NCT02595385
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Traditional Chest drains
Traditional Chest Drains
Chest drains as usual with no possibility to reinfuse lost blood
CARDIOPAT
CARDIOPAT Cell Saver after Surgery
CARDIOPAT
Cell Saver System at bedside for ICU stay
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CARDIOPAT
Cell Saver System at bedside for ICU stay
Traditional Chest Drains
Chest drains as usual with no possibility to reinfuse lost blood
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cardiochirurgia E.H.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cardiochirurgia E.H.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiochirurgia European Hospital
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.